Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Anti-cancer peptides (ACPs) selectively kill tumor cells through membrane disruption, intracellular target engagement, and immune activation. Recent structural and computational advances have clarified structure-activity relationships, enabling rational engineering via cyclisation, D-amino acid incorporation, and nanoparticle delivery. This review integrates current understanding of ACP-cellular i...
Brucellosis, a neglected zoonosis caused by intracellular Brucella bacteria, remains a formidable global public health challenge, especially in developing regions. The notorious ability of Brucella to evade host immunity and establish chronic focal infections limits the utility of traditional diagnostic methods like bacterial culture and serology for early detection, therapeutic monitoring, and di...
BACKGROUND: Nasopharyngeal carcinoma (NPC) is partially driven by epithelial-mesenchymal transition (EMT). We identified potential EMT-related biomark...
Cadmium (Cd) is a toxic heavy metal strongly implicated in lung adenocarcinoma (LUAD) through mechanisms involving oxidative stress, epigenetic dysreg...
Oncolytic peptides (OPs) represent a promising class of cancer therapeutics capable of rapidly lysing tumor cells and activating antitumor immunity. H...
Accurate pathology diagnosis has remained the most essential factor in providing optimal breast cancer care across the globe. Core needle biopsies acc...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal forms of cancer, with a five-year survival rate below 10% primarily due to late...
Single-cell mechanical profiling of deformations has become a promising method of identifying a functional biomarker in patients with blood cancers. B...
Metabolites exert pleiotropic effects that govern tumor progression. This review evaluates current platforms and technologies for metabolite detection...
Rare tumor diseases are difficult to diagnose and there is a lack of routine diagnostic procedures. Approaches must be found that allow comprehensive ...
Recent advances in deep learning have significantly improved the accuracy and efficiency of disease classification in digital pathology. Early diagnos...
Neuro-cancer crosstalk plays an important role in the development and progression of Glioblastoma (GBM), but its specific mechanisms remain incomplete...
BACKGROUND: There is a recent surge in interest in the application of artificial intelligence (AI) in prostate cancer (PCa). When evaluating PSMA PET ...
Compact robotic systems offer new opportunities for spinal procedures outside the operating room, but their potential for small-scale interventions su...
Accurate prediction of Homologous Recombination Deficiency (HRD) is vital for personalized cancer therapy, yet genomic assays are often costly and com...
Growing evidence suggests that lipid metabolic reprogramming occurs in oral cancer (OC). We characterized circulating metabolic alterations associated...
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer-related mortality worldwide, with a high prevalence and poor prognosi...
Histopathological grading remains the cornerstone of risk stratification in prostate cancer, yet conventional Gleason-based assessment is limited by i...
BACKGROUND: Definitive chemoradiotherapy for head and neck squamous cell carcinomas (HNSCC) carries significant long-term toxicities, with elective ne...
Point-of-care (POC) biosensing holds great promise for noninvasive cancer diagnostics, as circulating tumor DNA (ctDNA) serves as a minimally invasive...